Position in NVS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$6,268
New position
Shares Held
40
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,557
of 1,603 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MCDONALD PARTNERS LLC holds $28,881,483 across 13 Drug Manufacturers - General names. NVS ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
32,121 | $8,157,770 | |
| 2 | AMGN |
Amgen Inc
|
15,929 | $5,768,209 | |
| 3 | ABBV |
AbbVie Inc.
|
20,808 | $5,236,125 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
23,016 | $2,907,841 | |
| 5 | PFE |
Pfizer Inc
|
101,152 | $2,435,740 | |
| 6 | MRK |
Merck & Co., Inc.
|
13,987 | $1,797,329 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
28,302 | $1,630,761 | |
| 8 | LLY |
ELI LILLY & Co
|
678 | $813,213 |
All Filings in NVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,268 | 40 | Shares | Sole | 2026-07-28 | |
| No filing history on record for this holder in this stock. | ||||||